- AU$12.35m
- AU$15.41m
- AU$0.27m
Australia's Memphasys jumps on European regulatory approval for product
Brief: Memphasys Seeks Trading Halt Due To Pending Regulatory Milestone Announcement
Brief: Memphasys Ltd Says Position Of CEO Been Made Redundant And David Ali Will Depart Co
Brief: Memphasys Expands Felix Commercial Footprint In Japan
Brief: Memphasys To Raise A$1.1 Million At Issue Price Of A$0.003 Per Share
Brief: Memphasys Raises A$0.84M At A$0.003 Per Share, Rights Issue Up To A$1.12M
Brief: Memphasys Requests Trading Halt
Australia's Memphasys surges on exclusive deal with Qatar co
Brief: Memphasys Seeks Trading Halt
Australia's Memphasys soars on upbeat trial results for sperm selection device
Brief: Memphasys Seeks Trading Halt
Brief: Memphasys Signs Letter Of Intent With Heranova
Brief: Memphasys Announces Order For Felix System To Evaluate Suitability In UAE
Brief: Memphasys Announces A$2 Million Capital Raising
Brief: Memphasys Seeks Trading Halt
Brief: Memphasys Entered Into Exclusive Distribution Agreements With Local Units Of Vitrolife Group
Brief: Memphasys Says David Ali Appointed Full Time Chief Executive Officer
Brief: Memphasys Says Felix System Sales Orders Accelerate In Japan
Australia's Memphasys hits over 7-week high after co wins orders from Japan